OTCPicks.com

For Monday, June 2nd

USSUE, MGRN, MPPC, XSNX, NXPC
TPIM, PROW, IDMI, FMNT, PTPE, GLCC, AWEC, SOLI, PTEK

Our Stocks to Watch today include USA Superior Energy Holdings Inc. (OTCBB: USSUE), Monogram Energy Inc. (OTC: MGRN), myPhotopipe.com Inc. (OTC: MPPC), XsunX Inc. (OTCBB: XSNX), NeXplore Corp. (OTC: NXPC), TapImmune Inc. (OTCBB: TPIM), Progress Watch Corp. (OTC: PROW), IDM Pharma Inc. (NASD: IDMI), Fremont General Corp. (OTC: FMNT), Pantera Petroleum (OTCBB: PTPE), Good Life China Corp. (OTC: GLCC), Ameriwest Energy Corp. (OTCBB: AWEC), Solei Systems Inc. (OTC: SOLI) and PokerTek Inc. (NASD: PTEK).

FEATURED COMPANY

QMCI

USA SUPERIOR ENERGY (OTCBB: USSUE)

Detailed Quote: http://www.otcpicks.com/quotes/USSUE.php

Company Profile:
http://www.otcpicks.com/usa-superior-energy/usa-superior-energy-3.htm

USA Superior Energy Holdings, Inc., a development stage company, operates in the energy industry in the United States. The company, through its wholly owned subsidiary, USA Superior Energy, Inc., engages in the development, ownership, and operation of prospects and energy projects in East and Southeast Texas. It also focuses on using nitrogen technology to recharge and produce oil and gas from under-pressured partially depleted reservoirs. The company was founded in 2005 and is based in Houston, Texas.

USSUE News:

June 2 - USA Superior Reports First Quarter 2008 Results

USA Superior Energy Holdings, Inc. (OTCBB: USSUE) (the "Company"), a Houston-based energy company focused on acquiring, owning, operating and applying enhanced oil recovery ("EOR") techniques to existing shallow fields of oil and gas that have been idle or marginally producing, is reporting its operating results for the quarter ended March 31, 2008 and its filing of an amended Quarterly Report on Form 10-Q/A for the three months ended March 31, 2008.

For the quarter ended March 31, 2008, the Company's net loss decreased to $516,740, compared to the same quarter 2007 net loss of $3,379,474. The major components of the first quarter 2008 loss were general and administrative expenses of $463,751 including stock based compensation of $207,436. Stock based compensation in the first quarter of 2008 included warrants issued to the Company's financial consultant and shares issued to a key employee. This compares to general and administrative expenses of $3,375,085 including stock based compensation of $3,020,000 in the quarter ended March 31, 2007 related to the reverse merger and compensation of employees and consultants in the Quarter Ended March 31, 2007.

Revenues for the quarter ended March 31, 2008 increased to $115,563 from $15,443 in the same period of 2007. This increase reflects a full quarter of operations of the Bateman Project which was acquired at the comparable quarter's end in 2007. Sales volume for the first quarter 2008 was a net 1,322 barrels, which was a substantial increase over third quarter and fourth quarter volume of 727 barrels and 139 barrels, respectively. This increase represents the successful results of workover and treatment operations in the Bateman Field performed during the first quarter of 2008. The Company anticipates a further sales volume increase for the second quarter of 2008 as sales volume has exceeded a net 1,183 barrels in the month of May 2008. The Company realized an average price of $91.63 per barrel during the quarter ended March 31, 2008.

Mr. Rowland Carey, Chairman and CEO, stated: "For the remainder of 2008 we remain focused on the continuing workover and acceleration of revenue from our Bateman Project and preparations for EOR operations to begin in the second half of 2008. We are also seeking to strengthen our management team, increase our capital base to fund our EOR operations and growth to continue our business strategy of acquiring and joint venturing shallow fields of oil and gas that have been idle or marginally producing."

The following chart summarizes the Company's sales of oil and gas since its acquisition of the Bateman project on March 20, 2007:

Sales Chart

The Company's ability to maintain and increase sales from recent levels is dependent on its ability to raise funds to correct its working capital deficit and for the investment of additional funds into the extensive maintenance, workover and planned enhancement operations to accelerate the realization of production volumes.

On May 30, 2008, and substantially ahead of the OTCBB grace period deadline of June 20, 2008, the Company also filed an amended Quarterly Report on Form 10-Q for the three months ended March 31, 2008, which included the required management certifications and independent registered public accounting firm's review of its consolidated financial statements included in its Quarterly Report on Form 10-Q for the three months ended March 31, 2008. In addition, subsequent to the filing of our Form 10-Q, the Company concluded that it was required to restate previously issued financial statements for the quarters ended March 31, 2008 and 2007. Management determined that a restatement was necessary in respect of the following: revision of stock based compensation for 2007, revision of the valuation of stock and warrants to be issued under a financial services contract in 2008, correction of the timing of recording certain transactions in 2007. As a result of these revisions to our financial statements, our previously issued financial statements for the quarters ended March 31, 2008 and 2007 (which were included in our Quarterly Reports on Form 10-Q) should no longer be relied upon. Restated financials for the quarters ended March 31, 2008 and 2007 are included in the filing on Form 10-Q/A filed on May 30, 2008. These changes do not effect the financial statements contained in the Annual Report on Form 10-K for the year ended December 31, 2007, which may continue to be relied upon.

It is anticipated that the Company's stock symbol will retain the "E" designation until such time as the OTCBB can review the amended filing to determine the Company's compliance with all applicable reporting requirements.

A summary of our financial results for the quarter ended March 31, 2008 are provided below. For more information, please visit us at www.usa-superior.com.


FEATURED COMPANY

QMCI

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

Detailed Quote: http://www.otcpicks.com/quotes/MGRN.php

Company Profile:
http://www.otcpicks.com/monogram-energy/monogram-energy.htm

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

May 13 - Monogram Energy Inc. Continues to Produce in Corsicana, Texas

Monogram Energy, Inc. (OTC: MGRN), an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties, announced that the Company will begin workovers on 3 additional wells early next week in Corsicana, Texas. These wells are part of the T.W. Martin lease and are expected to produce an estimated 270 barrels a month. The workover is expected to take one week to complete and will increase the total number of wells in production to eight. The T.W. Martin lease comprises 70 acres with 12 wells and is located in Navarro County, which produces around 600,000 barrels annually.

"These next three wells should provide us with some nice operating cash flow," stated Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc. Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.


FEATURED COMPANY

QMCI

MYPHOTOPIPE.COM INCORPORATED (OTC: MPPC)
"Up 20.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MPPC.php

Company Profile:
http://www.otcpicks.com/myphotopipe/myphotopipe-2.htm

MyPhotopipe.com Inc. is a US-based provider of online digital photo processing and related services catering to high-end amateur and professional photographers. The Company’s primary web portal is www.myphotopipe.com. Its services include photo finishing and printing, online sharing, photo books, digital photo templates, and online hosting and selling of photographs. The Company provides services to more than 18,500 professional and high-end amateur photographers nationwide; more than 190,000 copies of its software have been downloaded and are in use.

MPPC News:

May 16 - myPhotopipe.com Reports First Quarter Operating Results

Revenues Rise 26%, Gross Profit Margins Expand to 74%

myPhotopipe.com, Inc. (OTC: MPPC), a web-based online provider of digital photo processing and related services, announced its operating results for the first quarter of 2008.

For the three months ended March 31, 2008, revenues increased 26% to $366,329, compared with revenues of $289,869 in the first quarter of 2007. Gross profits increased 42% to $270,373 (73.8% of revenues), versus $189,864 (65.5% of revenues) in the prior-year quarter. The Company reported a net loss of ($73,705) in the most recent quarter, versus a net loss of ($15,753) in the three months ended March 31, 2007.

"myPhotopipe.com continued to post excellent gains in revenues during the most recent quarter, with an increase of 26% over prior-year levels," stated L. Douglas Keeney, Chief Executive Officer of the Company. "That said, a significant design initiative related to the overhaul of our web site made unexpectedly good progress in January, and we elected to accelerate its launch, which in turn necessitated a concurrent increase in our search engine buys. Accordingly, we realized a slightly higher loss for the period than we anticipated, but we have been extremely pleased with the initial results from the new web site, as measured in a sharp increase in customer acquisitions, excellent industry notices, and continued revenue growth during April."

"New product introductions continued at our historical pace, which by any measure is rapid and well accepted by the market. Our gallery wraps and mounted products have been well received by customers, as has our pioneering PRPrintsPro platform that is now being used by many professional sports organizations. myPhotopipe.com's portfolio of greeting cards, a significant vein of revenue that we intend to vigorously mine, has increased by several hundred SKUs since the beginning of the year. Our project to allow local stationery stores to access more than 600 photo greeting cards appears to be progressing towards a beta in the second quarter. And finally, our industry data couldn't be better. Owners of digital cameras are making prints at historically high and growing levels, and online ordering with direct mail delivery is the channel of fulfillment that is expanding significantly faster than retail, kiosks or any other method of purchasing prints."

"We're an online lab serving the needs of professional and serious amateur photographers," continued Keeney. "This is a segment not all of us understand, so allow me this final thought. According to a recent InfoTrends study, professional photographers are themselves a $5 billion industry. They shoot pictures and earn 80%+ of their mean annual revenues of $130,000 by selling photographic prints. What's our value proposition to them? In a nutshell it is as follows. Because they waited for high-end digital cameras, professional photographers were slower than the consumer to switch to digital technology. But now, the switch is underway in earnest. Ironically, at the very same time these photographers are 'going digital', more than half of their local camera stores, where they went for photo processing, have closed, so they are going online to find a new photo processor. What do they see? Photo mousepads and photo coffee mugs and photo t-shirts — all sorts of 'cute' ways to share your photos. That's not what professionals are looking for. They're searching for a lab that focuses on making a top notch, professional print at a price that is competitive to any lab in the nation. That's a description of myPhotopipe.com. That's our value proposition. Using our products our customers can make a living. That's a wonderful position to be in. We believe we're in the right place at the right time, serving a lucrative slice of the digital photography market during a period of extensive brand switching. With persistence and steadfastness, we will emerge as one of the top brands in the business."


FEATURED COMPANY

IMAGE

XSUNX INCORPORATED (OTCBB: XSNX)

Detailed Quote: http://www.otcpicks.com/quotes/XSNX.php

Company Profile: http://www.otcpicks.com/xsunx/xsunx.htm

Xsunx, Inc., a thin-film photovoltaic (TFPV) company, focuses on developing thin film photovoltaic (TFPV) amorphous silicon solar cell manufacturing processes to produce TFPV solar modules. Its product includes XsunX ASI-120 module, which is a 125 peak watt TFPV solar module utilizing glass substrates and a proprietary semiconductor manufacturing system. XsunX ASI-120 provides for a module delivering high power output, and size and framing that would allow for the use of various existing mounting systems. The target markets for the TFPV solar module include solar farms, government agencies, and utility companies, as well as power purchase agreements and large commercial installations worldwide. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is headquartered in Aliso Viejo, California.

XSNX News:

May 29 - RedChip Visibility Initiates Research Coverage On XsunX Inc.

RedChip Visibility, a division of RedChip Companies, Inc., has initiated coverage on XsunX, Inc. (OTCBB: XSNX), a company engaged in manufacturing and commercializing thin-film photovoltaic (TFPV) solar cells utilizing amorphous silicon in the growing solar market.

Neha Bhargava, MBA, RedChip Research Analyst, reported:

“XSNX has spent the last three years focused on research with a photovoltaic material called amorphous silicon to develop an amorphous silicon thin-film photovoltaic (TFPV) solar cell manufacturing process to produce TFPV solar modules. The Company is moving in the right direction, exploiting opportunities in the thin-film solar PV market, which we believe will rapidly grow, as it offers the lowest manufacturing cost per watt at the module level and will likely maintain a cost per watt advantage over the more dominant crystalline silicon-based modules.”

“XSNX has announced plans to build a multi-megawatt, TFPV solar module production facility in Oregon. This has provided an imperative swing to XSNX's business model by focusing on the manufacturing and commercializing of TFPV solar cells and puts XSNX on the right path to seize revenue and profit opportunities in the global solar energy market as the Company heads toward commercialization of solar cells,” she continued.

“We initiate coverage of XSNX with a 'Speculative Buy' rating and a 12-month target price of $1.28,” Bhargava concluded.

To receive a complimentary copy of the RedChip Visibility Initial Research Report for XsunX Inc., visit:

www.redchip.com/visibility/about.asp?page=vreport&reportid=111&from=05292008pr.

ABOUT REDCHIP COMPANIES INC.

RedChip Companies is an international, small-cap research and financial public relations firm with offices in Maitland, Florida; Bangalore, India; and Beijing, with affiliates in New York and San Diego. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(tm), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Internet TV(tm), and RedChip Radio(tm). To learn more about RedChip's products and services, visit www.redchip.com/visibility/productsandservices.asp.


FEATURED COMPANY

QMCI

NEXPLORE CORPORATION (OTC: NXPC)

Detailed Quote: http://www.otcpicks.com/quotes/NXPC.php

Company Profile: http://www.otcpicks.com/nexplore/nexplore.htm

NeXplore Technologies is developing a Web 2.0 search engine and an assortment of social networking portals and tools that will enable users to personalize their Web experience and tailor it to their unique needs, interests, and online pursuits. The Company’s social computing platform, MyCircle.com, offers an enhanced, user-friendly graphical interface search engine, combined with innovative backend technology, which enables users to improve the way they connect with information and other people on the Worldwide Web. MyCircle’s Web 2.0 interface provides users with an online tool for sharing their Blogs, Voice-Over IP, photos and documents, podcasts and videocasts, classified advertising, instant messages, SMS text messages, Chat and personal profiles.

NXPC News:

May 30 - WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for NeXplore Corporation

WallSt.net's 3-Minute Press Show, a daily video program hosted by WallSt.net reporter Tracee Tolentino, features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.

A recent show included a discussion with Scott Grizzle, Chief Marketing Officer for NeXplore Corp. (OTC: NXPC) (www.nexplorecorporation.com).

Visit http://tv.wallst.net/3-min-press/3-min-press.php for a complete broadcast schedule.


STOCKS TO WATCH

TAPIMMUNE INCORPORATED (OTCBB: TPIM)
"Up 41.94% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/TPIM.php

TapImmune is a biotechnology company specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company's lead product, TAP vaccine, performs a key step in moving characteristic markers called antigens to the surfaces of cells. TAP, or Transporters Associated with Antigen Processing, are proteins responsible for supplying tumor-associated antigens (markers) and viral antigens to the surface of infected cells. Without TAP, there are no cancer markers, so the immune system fails to spot the rogue cells and the cancerous cells can grow undetected. The Company's vaccine has shown, in preclinical tests, effective restoration of TAP which restores and augments the marker (antigen) presentation and subsequent recognition and killing of cancer cells by the immune system. The TAP molecule also works as an adjuvant or 'accelerant' to enhance targeted vaccines against infectious diseases. The global vaccine market is expected to grow from $13 billion in 2007 to $21 billion in 2010. TapImmune is preparing GLP manufactured materials for the commencement of toxicology studies on the AdhTAP vaccine, leading to the initiation of a Phase I clinical trial. The Company is also developing a TAP-based vaccine adjuvant which existing preclinical data suggest increases the efficacy of targeted prophylactic vaccines by up to 1000 times. Additional information on the Company can be found on its Web site at www.TapImmune.com.

TPIM News:

June 2 - Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer

TapImmune Inc. (OTCBB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced that an independent third party research article in the Journal of Investigative Dermatology has confirmed and corroborated that a TAP incorporated vaccine should be considered as a therapy for the treatment of cancer, in this case, Melanoma.

The article, in advance online publication 3 April 2008, titled, "Restoration of the Expression of Transporters Associated with Antigen Processing in Human Malignant Melanoma Increases Tumor-Specific Immunity," is yet another promising research study that confirms and corroborates the TAP incorporated vaccine. There is now a vast amount of research data supporting and corroborating the initial description of the promising effect of TAP as a cancer therapy and their effect on tumor recognition.

TapImmune patented this novel cancer treatment in 2002 and has been developing it for clinical evaluation. This year it is our intention to bring all this work and research forward by initiating our first cGMP vaccine manufacturing contract. This will enable us to initiate toxicology testing and begin protocol design for a First-In-Man trial (phase 1). Updates are available on the company's website, so visit www.tapimmune.com and sign up for additional news alerts.

To read the full article referenced in this release, visit:

www.nature.com/jid/journal/vaop/ncurrent/full/jid200810a.html.


PROGRESS WATCH CORPORATION (OTC: PROW)
"Up 51.22% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PROW.php

Progress Watch Corporation (PROW) is a company dedicated to independently provide high end, innovative, reliable, stable, flexible and unique Swiss made mechanical watch movements to the elite of the Swiss watch industry.

PROW News:

June 2 - Progress Watch Corporation (PROW) Reports Confirmation of a New Contract for Its 'START' Tourbillon Watch Movement

Progress Watch Corporation (OTC: PROW), reports that following its success at the watch shows in Basel and Geneva in April, it has received confirmation of a further contract for its exclusive three-axis START Tourbillon movement. The contract is for delivery of movements over a minimum of a 3-year period.

Progress Watch now has four agreements with exclusive watch manufacturers for delivery of its exclusive and innovative START movement. Progress Watch now holds an order reserve exceeding 10 million Swiss francs.

The management of Progress is in the final stages of several other negotiations with clients, and expects these negotiations to result in further contracts in the near future. Several new watch manufacturers have approached Progress for the use of its START movements, as well as for the development of other ‘Haute Horlogerie’ watch concepts.

Progress Watch has extended the number of variants offered to customers, and currently offers five variants of its START Tourbillon movement. Further variants with additional functions are under development. These expanded designs are being developed to satisfy the different luxury watch brands’ increasing demand for unique and individual features.

The management of Progress Watch has decided to relocate its prototyping and assembly arm, Calibrum SA, from La Chaux-de-Fonds to its extended premises in Murten, to significantly improve the company’s flexibility to respond to the high demands of the luxury watch industry.

The highly sophisticated mechanical movements are entirely manufactured in Switzerland and meet the highest standards of the ‘Haute Horlogerie’ brands.

Progress Watch Corporation (PROW) is a company dedicated to independently provide high end, innovative, reliable, stable, flexible and unique Swiss made mechanical watch movements to the elite of the Swiss watch industry.


IDM PHARMA INCORPORATED (NASD: IDMI)
"Up 7.66% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/IDMI.php

IDM Pharma, Inc., a biopharmaceutical company, engages in the development of products to treat and control cancer. It develops product candidates to destroy residual cancer cells and to stimulate an immune response and prevent tumor recurrence. The company's products include L-MTP-PE/MEPACT, a Phase 3 clinical trial completed liposomal muramyl-tripeptide phosphatidylethanol- amine, for the treatment of osteosarcoma; BEXIDEM, a Phase 2 clinical trial completed product for the treatment of bladder cancer; UVIDEM, a Phase 2 clinical trial dendritophage and melanoma tumor cell lysates product, for the treatment of melanoma; IDM-2101, a multiple tumor-associated CTL epitopes Phase 2 clinical trial product, for the treatment of non-small cell lung cancer; and COLLIDEM, a Phase 1/2 dendritophages and tumor associated antigen peptides product, for the treatment of colorectal cancer. It has operations in the United States and France. IDM Pharma has collaboration agreements with sanofi-aventis S.A; Medarex, Inc.; GenPharm International, Inc.; Novartis; and Biotecnol S.A. It also has intellectual property licensing and framework agreement with Institut de Recherche Pierre Fabre and Pierre Fabre Medicament S.A. The company was incorporated in 1987 and is based in Irvine, California.

IDMI News:

June 2 - IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients

Data presented at 44th American Society of Clinical Oncology (ASCO) annual meeting further supports improvement in median survival vs. external controls

IDM Pharma, Inc. (NASD: IDMI) announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.

"We continue to be encouraged by the positive trend in overall survival we are seeing in patients treated with IDM-2101," said Minal Barve, M.D., practice director, Mary Crowley Cancer Research Center. "Based on the results to date, further clinical study is warranted to confirm the potential of IDM-2101 as a treatment option for patients with non-small cell lung cancer."

Trial Design and Results

The Phase 2 open label, non-randomized trial, was designed to assess one-year patient survival, overall survival and vaccine immunogenicity in HLA-A2 positive patients with stage IIIb, IV or recurrent NSCLC. Patients were required to have tumor volume less than 125 cm2 with no limits on prior chemotherapy. Sixty-eight patients were enrolled in the trial (sixty-three treated with one or more doses) with the last patient enrolled in March 2006. Patients are still being followed for long-term survival.

Results are as follows:

* One-year survival IDM-2101 patients versus HLA-A2 negative patients (n=72) but otherwise comparable group — 60 percent versus 49 percent.
* Median survival (IDM-2101 versus comparator group) — 17.3 months versus 12.0 months.
* Stable disease >/= 3 months — 54 patients (86%) treated with IDM-2101.
* Tumor Response IDM-2101 — One patient had complete response; one patient had partial response.
* 17 patients (27%) treated with IDM-2101 continued treatment for one year with no evidence of progressive disease
* 14 patients (22%) treated with IDM-2101 continued treatment for two years with no evidence of progressive disease
* Measurable immune response — 91 percent of patients treated with IDM-2101, who were tested for immune response, had a measurable response to at least one of the epitopes included in the vaccine with 64 percent responding to at least three of the epitopes.
* Toxicities attributable to the vaccine were mild and consisted primarily of injection site reactions.

"These results further support the survival trend and safety of IDM-2101 and will serve as a basis in determining an appropriate clinical pathway for this important treatment," said Timothy P. Walbert, president and chief executive officer, IDM Pharma, Inc.

ABOUT IDM-2101

IDM-2101 includes nine CTL epitopes from four tumor associated antigens (TAA) including two proprietary native epitopes and seven modified, or analog, epitopes and one universal epitope a source of T-cell help. Tolerance to TAA, which is a failure of the immune system to recognize the cancer as diseased tissue, is broken by using these analog epitopes which enhance the potency of the T cell response. The Phase 2 IDM-2101 study has been ongoing since late 2004 and patient treatment has been completed. Long-term follow-up is ongoing for overall survival.

ABOUT LUNG CANCER

Lung cancer continues to be a major health problem with a very high mortality rate and represents the leading cause of cancer death in the United States. According to the American Cancer Society, approximately 213,000 new lung cancer cases will be diagnosed in the United States in 2007, and an estimated 160,000 patients will die from lung cancer. The American Cancer Society also estimates that non-small cell lung cancer represents 87 percent of all lung cancers.

In the European Union, non-small cell lung cancer represents 75 percent of all lung cancer. In addition, approximately 130,000 new cases will be diagnosed in 2007 in the top five markets (France, Germany, Italy, UK & Spain).


FREMONT GENERAL CORPORATION (OTC: FMNT)
"Up 64.06% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/FMNT.php

Fremont General Corporation operates as a financial services holding company in the United States. The company, through its subsidiary, Fremont General Credit Corporation, owns a California bank subsidiary, Fremont Investment & Loan, which provides various financial services. It offers certificates of deposit, savings accounts, and money market deposit accounts insured by the Federal Deposit Insurance Corporation through its 22 branches in California. The company was founded in 1963. It was formerly known as Lemac Corporation and changed its name to Fremont General Corporation in 1973. The company is based in Brea, California.

FMNT News:

June 2 - Fremont General Enters Into Forbearance Agreement With Majority Senior Debt Holder

Fremont General Corporation (OTC: FMNT) ("Fremont General" or the "Company"), doing business primarily through its wholly-owned bank subsidiary, Fremont Investment & Loan ("Bank"), announced that the Company entered into a Forbearance Agreement (the "Agreement") with Tennenbaum Multi-Strategy Master Fund ("Tennenbaum"), the majority holder of the Company's $166.5 million of Series B 7.875% Senior Notes due March 2009 ("Senior Notes"), which is intended, among other things, to facilitate the closing of the transactions contemplated by the Purchase and Assumption Agreement (the "Purchase Agreement"), dated April 13, 2008, by and among the Company, the Bank, CapitalSource, Inc. ("CapitalSource") and certain subsidiaries of each company, which provides for the sale by the Bank of certain designated assets and certain liabilities, including all of the Bank's deposits to CapitalSource Bank, a proposed California industrial bank and indirect wholly-owned subsidiary of CapitalSource.

Pursuant to the terms of the Agreement, Tennenbaum agreed that during the Forbearance Period (as defined below), it will not, and will direct the trustee of the Senior Notes not to, take, or cause another person to take, any action, to accelerate (or cause the acceleration of) the maturity of the Senior Notes or to otherwise enforce payment of the overdue principal on the Senior Notes, or to exercise any other default-related rights and remedies available to Tennenbaum against the Company under the Indenture, dated March 1, 1999 (the "Indenture") for the Senior Notes or applicable law with respect to the Senior Notes. Upon the expiration of the Forbearance Period, Tennenbaum will be entitled, but not required, to exercise any of its rights and remedies under the Agreement, the Indenture, or applicable law. In accordance with the Agreement, the Company will pay for certain fees and expenses incurred by Tennenbaum in connection with the Agreement. The "Forbearance Period" means the period commencing from May 28, 2008 through the earliest to occur of (i) the consummation of the transactions contemplated by the Purchase Agreement; (ii) the Bank's banking regulators denial of the transactions contemplated by the Purchase Agreement; (iii) the termination of the Purchase Agreement; or (iv) such earlier date upon the occurrence of certain events.

Also under the terms of the Agreement, Tennenbaum, as the majority holder of the Senior Notes, instructed the trustee to enter into the Supplemental Indenture (the "Supplemental Indenture"), which was effective on May 28, 2008. The Supplemental Indenture modifies the terms of the Indenture to, under certain circumstances, prevent any portion of the Senior Notes from being declared immediately due and payable under any provision of the Indenture, other than an event of default that occurs relating to insolvency or bankruptcy proceedings, until after the Forbearance Period. The Supplemental Indenture will have the effect of not permitting other holders of the Senior Notes to exercise their remedy, if any, to accelerate the maturity of the Senior Notes that they otherwise would have been entitled to under the Indenture during the Forbearance Period.

As previously reported in a Current Report on Form 8-K filed on March 18, 2008, the Company delayed its semi-annual interest payment of approximately $6.6 million which was payable on March 17, 2008 on the Senior Notes and entered into negotiations with Tennenbaum. Under the terms of the Indenture, the Company's failure to pay such semi-annual interest payment constituted an event of default entitling Tennenbaum, as the holder of at least 25% of the principal amount of the Senior Notes, to declare the entire amount of the Senior Notes to be immediately due and payable.


PANTERA PETROLEUM (OTCBB: PTPE)
"Up 18.18% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PTPE.php

Pantera Petroleum, Inc. is a publicly traded oil and gas exploration company headquartered in Austin, TX with operations in Midland, TX, Pecos County, TX, and Asuncion, Paraguay. Our mission is to explore and discover new energy fields in North and South America. Our North American assets include a 10% working interest in the Block 83 84 Project in the West Gomez field in Texas, with combined potential reserves of 27 BCF of gas and 50,000 barrels of oil. In South America, Pantera has rights to five concessions in northern Paraguay, covering nearly 4 million acres, with combined potential reserves of 6.7 TCFE of gas or 1.1 billion barrels of oil.

PTPE News:

June 2 - Pantera Petroleum Updates Drilling Progress on Block 83 84 Project

Pantera Petroleum (OTCBB: PTPE) (Frankfurt: 4PP.F) announced that its Sibley 84 #1 re-entry well drilling is on schedule for completion to resume commercial production of natural gas, having reached a drill depth of approximately 18,300 feet after clearing eleven of its twelve concrete plugs on the way to 22,820 feet. Located on 1280 acres in the prolific West Gomez Field in Texas, the Block 83 84 Project JV ("Block 83 84") consists of two re-entry wells, the Sibley 84 #1 and Gulf-Baker 83 #1, and one infill, shallow depth oil drill (Sibley 84 #2).

Stratco Operating Company ("Stratco"), our operating partner in the project, began the re-entry phase of Block 83 84 on April 1, 2008. The drilling rig was mobilized to location on Sibley 84 #1 along with the pump, water tanks, pipe racks and drilling string. Throughout April and May, Stratco successfully drilled through the first eleven cement plugs, circulating out debris to a total depth of 18,300 feet. At that depth, Stratco encountered substantial gas pressure which caused a closure of the blowout preventers. With the experience and expertise working on location, Stratco and Atlas Well Service were able to control the well and continue operations on schedule. This was a very exciting occurrence and gave a significant indication of this well's potential production.

We are currently at one of our last milestones to completing the Sibley 84 #1. Once Stratco mills the remaining bridge plug and the last concrete plug, it will finish circulating out the well and complete it to its depth of approximately 22,820 feet. The well will be logged, and the new data will be correlated with the well's historical data to determine the zones and depths to be perforated to resume commercial production of natural gas.

Upon completion of the Sibley 84#1, Stratco will re-enter a second well, the Gulf-Baker 83 #1. The infill drill, the Sibley 84 #2, is a shallow oil drill of roughly 4000 feet that will be completed soon thereafter. The primary objectives of Block 83 84 are the Ellenberger, Fusselman, Devonian, Upper and Lower Wolfcamp, Atoka and Yates 7 Rivers sands. The West Gomez Field has produced in excess of 5 TCF of natural gas over the past 40 years, and wells in this field have produced or booked remarkable reserves out of these horizon intervals. Block 83 84 can potentially produce 6.5 million cubic feet of gas per day from its two re-entry wells, along with 80 or more barrels of oil per day from the Sibley 84 #2. Based on published production data and geological and engineering calculations, recoverable reserves in the Block 83 84 Project are estimated to be more than 27 BCF of gas and 50,000 barrels of oil, of which Pantera has a 10% working interest.

"We are very pleased to be on schedule to re-commence the commercial production of natural gas on our first re-entry well in the near term, and we look forward to our additional wells to follow. We expect the next several weeks and months to be very exciting ones for our company and our shareholders as we bring the Block 83 84 wells back online and into production.", states Pantera Petroleum's CEO, Chris Metcalf.


GOOD LIFE CHINA CORPORATION (OTC: GLCC)
"Up 7.69% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GLCC.php

Good Life China Corporation operates a rapidly growing chain of franchised convenience stores based in Hebei Province, China. It employs advanced retail concepts such as e-commerce enabled POS/back office systems, and achieves significant economies of scale on the supply side of the business. It will be expanding geographically to neighboring Provinces, as well as offering a growing number of additional products and services, such as financial products, as it moves forward. The Company's North American operations comprise a number of online sub prime financial services, including; the Money Lending Business.com; Forex Trading; and Advanced Electronic Funds Management.

GLCC News:

June 2 - Good Life China Corporation Offers Expansion And Corporate Update

Good Life China Corp. (OTC: GLCC) (www.goodlifechina.com) begins June 2008 operations with 9 new stores, two are in Cangzhou, five are in Beijing, two are in Shijiazhuang. The company has signed up 15 new suppliers with audited online transaction of 1,682,200. The company sum of distribution is 117,760; and income of membership is 48,000; the income of distribution is 58,900. All sums reported in Chinese Yuan and converted in USD in company filings.

In other company updates, Mr. Yang, a company spokesperson, said: "The company has identified a couple of possible buyers for some of its North American assets. We were particularly interested in small public companies or at least much smaller size than us, and those that demonstrate vertical growth opportunities in their sector. Our reasoning is twofold. One reason is we are currently considering, and evaluating our corporate adviser's recommendation of spinning out this sale proceeds as a 1 time special dividend to our shareholders. At present, "insiders" own 80 million shares of GLCC. The second reason is, as currently issued restricted shares mature and become free trading (currently at 32 million shares), the company sees this dividend payment as one of the first of several incentives to attract long term shareholders instead of day traders and stock traders. GLCC is looking to reward its long term shareholders with this dividend, and also to target a buyer whose business growth will appreciate the dividends values for our shareholders far in excess of the present purchase price or agreed value. The issuer will make further updates on this planed sale/dividend, and expects to close the transaction in the next 30-45 days."


AMERIWEST ENERGY CORPORATION (OTCBB: AWEC)
"Up 23.08% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/AWEC.php

Ameriwest Energy Corp. is a growing, expertly managed energy company focused on producing underdeveloped oil resources in the prolific Rocky Mountain region of the United States. The company is striking a strategic balance between low-risk tertiary recovery projects and extensively mapped exploration plays with significant upside potential. Visit www.ameriwestenergy.com for more information.

AWEC News:

May 30 - Ameriwest Energy Completes Purchase of Skull Valley Oil Prospect

Ameriwest Energy Corp. (OTCBB: AWEC) ("Ameriwest" or the "Company") announced that it has closed the acquisition of the Skull Valley Oil Exploration Prospect lands and has advanced the final $300,000 property payment to Geochem Exploration.

Under the terms and conditions of the Bill of Sale the property title, drilling permit and operational control will be transferred to Ameriwest Energy in the coming weeks. The Agreement calls for Ameriwest to drill the permitted well, Skull Valley Federal 21-1 on or before September 1, 2008. Exploration Technologies, Inc., a third party engineering firm from Houston, Texas, identified that the similarities between the structural style (slump blocks), geologic column (reservoir rocks), and geochemical anomaly between the Grant Canyon field and the Skull Valley Prospect suggest that with almost 5000 leased acres (over 2000 acres in the heart of the geochemical anomaly) a 25 million to 35 million barrel potential is a realistic possibility.

Company President, Walter Merschat comments, "We are extremely pleased with the closing of the Skull Valley prospect as it represents the first of many acquisitions for the Company. We are currently working to secure funding for the first well and expect to announce a drilling spud date in the weeks to come."


SOLEI SYSTEMS INCORPORATED (OTC: SOLI)
"Up 23.75% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/SOLI.php

Solei consists of three divisions, Intelligent Tanning Systems: (ITS), Light Therapy Systems (LTS) and BioScience Systems, Inc. Paul Spivak, the Founder and CEO of Solei Systems, was the founder of Magic Tan, the world's number one UV free spray tanning Company. Solei Systems is also unique in that all of their machines and equipment are manufactured in-house which greatly reduces costs and dramatically increases efficiency at all levels.

SOLI News:

June 2 - Solei Systems, Inc. Announces Multinational Distribution Agreement and Initial Distributor Order

Solei Systems, Inc. (OTC: SOLI) (the "Company") announced that it had recently signed an agreement with a United Kingdom-based distributor that will provide for the sales of its products across all European countries, as well as Australia and other international markets.

Under terms of the distribution agreement, the Company received initial purchase orders exceeding $400,000 (U.S.) for product to be shipped promptly. Other conditions of the agreement call for continuous monthly purchase orders of at least $100,000 per month. Products covered under the distribution agreement include the Company's LED therapy products, and its poolside coin operated SPF 30 spray booth — the only one of its kind in the world.


POKERTEK INCORPORATED (NASD: PTEK)
"Up 25.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PTEK.php

PokerTek, Inc. engages in the development, manufacture, and marketing of electronic poker-related products for use in the gaming and amusement markets. The company's product line includes PokerPro system, an electronic poker table that provides an automated poker-room environment to tribal casinos, commercial casinos, cruise ships, and card clubs; and Heads-Up Challenge World Series of Poker edition, which is a heads-up amusement device that enables two players to compete against each other in a game of Texas Hold'em poker for entertainment purposes in non-gambling venues, such as bars and restaurants. It serves customers in approximately 66 sites in the United States, Canada, Macau, Panama, Germany, Australia, and South Africa. The company was founded in 2003 and is based in Matthews, North Carolina.

PTEK News:

May 28 - PokerTek Announces Quebec's 4th PokerPro Installation at Ludoplex Quebec

PokerTek, Inc. (NASD: PTEK) announced that it has installed an additional six PokerPro electronic Texas Hold’em devices for gaming, plus one for demonstration purposes, at Loto-Quebec’s Ludoplex Quebec property in Quebec City. This is the fourth PokerPro® installation in Quebec this year, and brings the total number of devices PokerTek has installed in the region to 50.

“Ludoplex Quebec is unique, in that it is a gaming and entertainment center, with harness racing located nearby,” said Chris Halligan, CEO of PokerTek. “We’re excited that Loto-Quebec has again chosen PokerPro, which has proven to be highly popular amongst gaming enthusiasts in Quebec, to enhance the existing offerings at this location. The amenities and entertainment provided at Ludoplex property in Quebec City are unlike anything we’ve seen, and we’re proud to have PokerPro be a part of such an amazing property.”

Ludoplex Quebec, located on the ExpoCite site in Quebec City, will feature PokerPro in addition to its 275 gaming positions. Also located on the ExpoCite site is the Hippodrome, also known as Sulky Quebec, which gives guests the opportunity to experience the excitement of live harness racing.

 
<< Start < Prev 81 82 83 84 85 86 87 88 89 90 Next > End >>

Results 441 - 445 of 613
Clicky Web Analytics